---
$id: https://graph.org.ai/products/commodity/51281610
$type: Product
source: UNSPSC
code: "51281610"
title: "Dibekacin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dibekacin

**UNSPSC Code**: 51281610
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 45ZFO9E525, chemically known as 3,4-dideoxykanamycin b but generally known as dibekacin, which bears US NIH Compound Identifier 3021. European Medicines Agency schedules Dibekacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07072MIG. The term DIBEKACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules dibekacin in its Anatomical Therapeutic Chemical (ATC) Classification. DIBEKACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dibekacin under HS 29419000 and SITC 54139. As of Q4 2014, DIBEKACIN remains the US FDA Preferred Term for this commodity. Dibekacin bears US NLM identifiers UMLS ID C0012024 and NCI Concept Code C79114. SMILES: O(C1C(O)C(OC2OC(CCC2N)CN)C(N)CC1N)C1OC(C(O)C(N)C1O)CO.

